Terms: = Gastric cancer AND NIN, KIAA1565, 51199, ENSG00000100503
12 results:
1. In vitro biodistribution studies on clinically approved FGFR inhibitors ponatinib, nintedanib, erlotinib and the investigational inhibitor KP2692.
Dömötör O; Mathuber M; Kowol CR
Eur J Pharm Sci; 2024 Jan; 192():106651. PubMed ID: 38013124
[TBL] [Abstract] [Full Text] [Related]
2. [A Case of Advanced Esophagogastric Junction Adenocarcinoma with Enlarged Lymph Node Metastases of the Middle Mediastinum and Intraperitoneal That Exhibited pCR by Preoperative SOX Therapy].
Mita K; Oda H; Sato M; Takahashi K; Shimaguchi M; Kobayashi N; Kouno M; Toyota T; Toyota N; Hatano M; Sasaki J; Kawamura Y; Nishida K
Gan To Kagaku Ryoho; 2023 Aug; 50(8):909-912. PubMed ID: 37608419
[TBL] [Abstract] [Full Text] [Related]
3. NOB1 Gene as a Potential Biomarker in Clinical Outcomes and Prognosis of Patients with gastric cancer.
Qi H; Wang Y
Clin Lab; 2018 Sep; 64(9):1469-1475. PubMed ID: 30274015
[TBL] [Abstract] [Full Text] [Related]
4. Diagnosis and therapies for gastric non-invasive neoplasia.
Kato M
World J Gastroenterol; 2015 Nov; 21(44):12513-8. PubMed ID: 26640329
[TBL] [Abstract] [Full Text] [Related]
5. MINT31 methylation in gastric noninvasive neoplasia: potential role in the secondary prevention of gastric cancer.
Negrini M; Miotto E; Sabbioni S; Cardin R; Rugge M; Tieppo C; Piciocchi M; Maddalo G; Nitti D; Farinati F
Eur J Cancer Prev; 2012 Sep; 21(5):442-8. PubMed ID: 22179688
[TBL] [Abstract] [Full Text] [Related]
6. Endoscopic submucosal dissection as a treatment for gastric noninvasive neoplasia: a multicenter study by Osaka University ESD Study Group.
Kato M; Nishida T; Tsutsui S; Komori M; Michida T; Yamamoto K; Kawai N; Kitamura S; Zushi S; Nishihara A; Nakanishi F; Kinoshita K; Yamada T; Iijima H; Tsujii M; Hayashi N
J Gastroenterol; 2011 Mar; 46(3):325-31. PubMed ID: 21107615
[TBL] [Abstract] [Full Text] [Related]
7. Helicobacter pylori, inflammation, oxidative damage and gastric cancer: a morphological, biological and molecular pathway.
Farinati F; Cardin R; Cassaro M; Bortolami M; Nitti D; Tieppo C; Zaninotto G; Rugge M
Eur J Cancer Prev; 2008 Jun; 17(3):195-200. PubMed ID: 18414189
[TBL] [Abstract] [Full Text] [Related]
8. Indefinite for non-invasive neoplasia lesions in gastric intestinal metaplasia: the immunophenotype.
Cassaro M; Rugge M; Tieppo C; Giacomelli L; Velo D; Nitti D; Farinati F
J Clin Pathol; 2007 Jun; 60(6):615-21. PubMed ID: 17557866
[TBL] [Abstract] [Full Text] [Related]
9. Non-invasive neoplasia of the stomach.
Rugge M; Nitti D; Farinati F; di Mario F; Genta RM
Eur J Gastroenterol Hepatol; 2005 Nov; 17(11):1191-6. PubMed ID: 16215431
[TBL] [Abstract] [Full Text] [Related]
10. Microsatellite instability and gastric non-invasive neoplasia in a high risk population in Cesena, Italy.
Rugge M; Bersani G; Bertorelle R; Pennelli G; Russo VM; Farinati F; Bartolini D; Cassaro M; Alvisi V
J Clin Pathol; 2005 Aug; 58(8):805-10. PubMed ID: 16049280
[TBL] [Abstract] [Full Text] [Related]
11. Hypermethylation of Chfr and hMLH1 in gastric noninvasive and early invasive neoplasias.
Homma N; Tamura G; Honda T; Jin Z; Ohmura K; Kawata S; Motoyama T
Virchows Arch; 2005 Feb; 446(2):120-6. PubMed ID: 15735977
[TBL] [Abstract] [Full Text] [Related]
12. Molecular and cellular phenotypic profiles of gastric noninvasive neoplasia.
Jin Z; Tamura G; Honda T; Motoyama T
Lab Invest; 2002 Dec; 82(12):1637-45. PubMed ID: 12480914
[TBL] [Abstract] [Full Text] [Related]
